iCAD, INC. (NASDAQ:ICAD)

CAPS Rating: 5 out of 5

The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.

Recs

0
Player Avatar jessikalu13 (< 20) Submitted: 6/26/2008 8:59:29 PM : Outperform Start Price: $3.23 ICAD Score: -83.09

As a cancer survivor, any comany that is trying to pinpoint cancer earlier and identify pathologies gets a KUDOS or two from me. We are starting to spend more money on cancer research and treatment and if someone can make a break through then great. If not, we eliminated one wrong step and made another leap.

Featured Broker Partners


Advertisement